Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.
Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States of America.
PLoS Genet. 2020 May 14;16(5):e1008747. doi: 10.1371/journal.pgen.1008747. eCollection 2020 May.
Abnormal fetal growth is a risk factor for infant morbidity and mortality and is associated with cardiometabolic diseases in adults. Genetic influences on fetal growth can vary at different gestation times, but genome-wide association studies have been limited to birthweight. We performed trans-ethnic genome-wide meta-analyses and fine mapping to identify maternal genetic loci associated with fetal weight estimates obtained from ultrasound measures taken during pregnancy. Data included 1,849 pregnant women from four race/ethnic groups recruited through the NICHD Fetal Growth Studies. We identified a novel genome-wide significant association of rs746039 [G] (ITPR1) with reduced fetal weight from 24 to 33 weeks gestation (P<5x10-8; log10BF>6). Additional tests revealed that the SNP was associated with head circumference (P = 4.85x10-8), but not with abdominal circumference or humerus/femur lengths. Conditional analysis in an independent sample of mother-offspring pairs replicated the findings and showed that the effect was more likely maternal but not fetal. Trans-ethnic approaches successfully narrowed down the haplotype block that contained the 99% credible set of SNPs associated with head circumference. We further demonstrated that decreased placental expression of ITPR1 was correlated with increased placental epigenetic age acceleration, a risk factor for reduced fetal growth, among male fetuses (r = -0.4, P = 0.01). Finally, genetic risk score composed of known maternal SNPs implicated in birthweight among Europeans was associated with fetal weight from mid-gestation onwards among Whites only. The present study sheds new light on the role of common maternal genetic variants in the inositol receptor signaling pathway on fetal growth from late second trimester to early third trimester. Clinical Trial Registration: ClinicalTrials.gov, NCT00912132.
胎儿生长异常是婴儿发病率和死亡率的一个风险因素,并且与成年人的心血管代谢疾病有关。遗传因素对胎儿生长的影响在不同的孕期可能有所不同,但全基因组关联研究仅限于出生体重。我们进行了跨种族的全基因组荟萃分析和精细映射,以确定与妊娠期间超声测量获得的胎儿体重估计值相关的母系遗传位点。数据包括通过 NICHD 胎儿生长研究招募的来自四个种族/民族的 1849 名孕妇。我们发现了一个新的全基因组显著关联,rs746039[G](ITPR1)与 24 至 33 周妊娠期间胎儿体重降低有关(P<5x10-8;log10BF>6)。额外的测试表明,该 SNP 与头围有关(P=4.85x10-8),但与腹围或肱骨/股骨长度无关。在一个独立的母婴对子样本中进行的条件分析复制了这些发现,并表明该效应更可能是母系的而不是胎儿的。跨种族的方法成功地缩小了包含与头围相关的 99%可信区间 SNP 的单倍型块。我们进一步表明,ITPR1 胎盘表达减少与男性胎儿中胎盘表观遗传年龄加速(胎儿生长减少的一个风险因素)相关(r=-0.4,P=0.01)。最后,由欧洲人出生体重中涉及的已知母系 SNP 组成的遗传风险评分与白人从中孕期开始的胎儿体重相关。本研究揭示了常见母系遗传变异在第二孕期晚期至第三孕期早期的肌醇受体信号通路对胎儿生长的作用。临床试验注册:ClinicalTrials.gov,NCT00912132。